Recent Progress in Base-Metal-Catalyzed Dearomative Reaction of N-Heteroarenes
Synthesis · 01.08.2025 · 57 (15) · 2289-2306
DOI: 10.1055/a-2516-2906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 01.08.2025. Verfasst von Qian Ni und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Three-dimensional nitrogen-containing heterocyclic compounds widely exist in many natural products and drugs. The dearomatization of N-heteroarenes and their derivatives have been recognized as one of the most important and powerful strategies for the rapid and efficient synthesis of various three-dimensional nitrogen-containing heterocyclic compounds. In this short review, the recent and representative advances in base-metal-catalyzed dearomatization of N-heteroarenes are summarized and discussed. 1 Introduction 2 Dearomatization of Indoles 2.1 Copper Catalysis 2.2 Nickel Catalysis 2.3 Cobalt Catalysis 2.4 Other Catalysts 3 Dearomatization of Pyridines, Quinolines, Isoquinolines, and Pyrazine 3.1 Copper Catalysis 3.2 Nickel Catalysis 3.3 Cobalt Catalysis 3.4 Other Catalysts 4 Summary and Outlook
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Ni, Q., Chen, Y., & Ma, Y. (2025). Recent Progress in Base-Metal-Catalyzed Dearomative Reaction of N-Heteroarenes. Synthesis, 57(15), 2289-2306. https://doi.org/10.1055/a-2516-2906
Vancouver
Ni Q, Chen Y, Ma Y. Recent Progress in Base-Metal-Catalyzed Dearomative Reaction of N-Heteroarenes. Synthesis. 2025;57(15):2289-2306. doi:10.1055/a-2516-2906
BibTeX
@article{Ni2025,
author = {Ni, Qian and Chen, Yaqi and Ma, Yuanhong},
title = {Recent Progress in Base-Metal-Catalyzed Dearomative Reaction of N-Heteroarenes},
journal = {Synthesis},
year = {2025},
volume = {57},
number = {15},
pages = {2289--2306},
doi = {10.1055/a-2516-2906}
}
EUVIMED